NCT06639841 (VRvsHY) is a NA clinical trial of Virtual Reality Psychotherapy in Performance Anxiety, sponsored by Grigore T. Popa University of Medicine and Pharmacy.

Who is sponsoring NCT06639841?

NCT06639841 is sponsored by Grigore T. Popa University of Medicine and Pharmacy.

What drugs are being tested in NCT06639841?

Interventions in NCT06639841: Virtual Reality Psychotherapy, Yoga.

What condition does NCT06639841 study?

NCT06639841 studies Performance Anxiety.

Is NCT06639841 still recruiting?

NCT06639841 is currently active, enrolled. Last updated 18 March 2025.

Last reviewed 2025-03-18 · How we verify

NCT06639841: VRvsHY

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Virtual Reality Psychotherapy and Yoga on Student Performance Anxiety

Active, enrolled NA Last updated 18 March 2025

What this trial tests

NA trial testing Virtual Reality Psychotherapy in Performance Anxiety in 70 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

15 September 2024

Primary endpoint
8 March 2025

31 July 2025

Quick facts

Lead sponsor	Grigore T. Popa University of Medicine and Pharmacy
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	70
Start date	15 September 2024
Primary completion	8 March 2025
Estimated completion	31 July 2025
Sites	1 location across Romania

Drugs / interventions tested

Virtual Reality Psychotherapy
Yoga

Conditions studied

Performance Anxiety — all drugs for Performance Anxiety →

Sponsor

Grigore T. Popa University of Medicine and Pharmacy

Who can join

Adults 18 to 35, any sex, with Performance Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this pilot clinical trial is to compare two non-pharmacological interventions-Virtual Reality (VR) and Yoga techniques-in reducing performance anxiety in students aged 16-35. Performance anxiety, commonly experienced during public speaking and examinations, affects academic performance and well-being. The main questions it aims to answer are: Does the VR-based guided meditation intervention reduce performance anxiety more effectively than Yoga-based relaxation techniques? Do participants experience better emotional regulation and improved quality of life with either intervention? Researchers will compare the VR intervention group to the Yoga intervention group to determine which intervention better alleviates anxiety symptoms and fosters improved emotional regulation during school performance. Participants will: Attend six to ten sessions of either VR-based guided meditation or Yoga-based relaxation over a period of four weeks. Complete questionnaires to assess their anxiety levels, emotional regulation, and quality of life before and after the intervention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparative Efficacy of Virtual Reality-Assisted Cognitive Behavioral Therapy Versus Yoga-Based Interventions for Reducing Performance Anxiety in Students: Protocol for a Randomized Controlled Trial.
Tofan CM, Măgurianu LA, Axinte M, Găină AM, et al · · 2025 · PMID 40587850 · DOI 10.2196/66112

Verify or expand the search:

Other Grigore T. Popa University of Medicine and Pharmacy trials

Trials by the same sponsor.

NCT07437755 — Thrombelastometry-guided Blood Component Administration Versus Standard of Care in Patients With Decompensated Liver Cir · NA · recruiting
NCT07237451 — Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients · recruiting
NCT07067294 — Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Cataract Surgery · NA · completed
NCT06662474 — Cognitive Impairment in Treated Breast Cancer Survivors: Possible Approaches · NA · not yet recruiting
NCT07181668 — Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Femto-Lasik Surgery · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06639841 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Grigore T. Popa University of Medicine and Pharmacy
Last refreshed: 18 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06639841.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing